Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for ...
Private equity firm Carlyle Group is reportedly in talks to acquire Baxter's kidney care spinoff for more than $4 billion.
, opens new tab kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter told Reuters on Friday. Shares of the Deerfield, Illinois-based firm rose ...
Carlyle Group (NASDAQ: CG) is considering acquiring Baxter International's (NYSE: BAX) kidney care spinoff, Vantive, in a deal valued at more than $4 billion, including debt.
Carlyle Group (CG) is in talks to acquire Baxter's kidney care unit. The companies started exclusive negotiations in late June and an agreement could be announced as soon as this week.
Private-equity firm Carlyle Group is in talks to buy Baxter International's spinoff kidney business, Vantive, The Wall Street ...